Clene Non Current Liabilities Total from 2010 to 2025

CLNN Stock  USD 3.22  0.04  1.26%   
Clene Non Current Liabilities Total yearly trend continues to be very stable with very little volatility. Non Current Liabilities Total is likely to grow to about 32.8 M this year. During the period from 2010 to 2025, Clene Non Current Liabilities Total quarterly data regression pattern had sample variance of 580 T and median of  78,337,000. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2010-12-31
Previous Quarter
25.9 M
Current Value
32.8 M
Quarterly Volatility
24.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Interest Expense of 2.2 M, Tax Provision of 0.0 or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 103, Dividend Yield of 0.0 or Days Sales Outstanding of 64.89. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Check out the analysis of Clene Correlation against competitors.

Latest Clene's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Clene Inc over the last few years. It is Clene's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Clene Non Current Liabilities Total Regression Statistics

Arithmetic Mean61,484,888
Geometric Mean54,942,174
Coefficient Of Variation39.17
Mean Deviation21,065,141
Median78,337,000
Standard Deviation24,083,514
Sample Variance580T
Range64.7M
R-Value(0.84)
Mean Square Error184.9T
R-Squared0.70
Significance0.00005
Slope(4,239,619)
Total Sum of Squares8700.2T

Clene Non Current Liabilities Total History

202532.8 M
202425.9 M
202313.6 M
202227.4 M
202144.4 M
202056.2 M

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Total25.9 M32.8 M
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out the analysis of Clene Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(5.67)
Revenue Per Share
0.049
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.52)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.